Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals
A collaborative clinic led by a pharmacist helps patients with gout to attain better clinical outcomes in the management of their condition, even in the presence of renal impairment, reports a Singapore study. The clinic provides safe, stepwise increments of urate-lowering therapy (ULT) in addition to serum uric acid (SUA) monitoring and adherence reinforcement through frequent initial visits.
Pharmacist-led collaborative gout clinic helps patients achieve serum uric acid goals
06 Feb 2023SPOTLIGHT shines on zolbetuximab-chemo potential for gastric/GEJ cancer
A combination regimen comprising zolbetuximab and mFOLFOX6* chemotherapy (CT) regimen showed potential as first-line treatment for claudin-18.2-positive**/HER2-negative (CLDN18.2+/HER2–) locally advanced unresectable or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, according to the primary findings of the phase III SPOTLIGHT trial.
SPOTLIGHT shines on zolbetuximab-chemo potential for gastric/GEJ cancer
06 Feb 2023Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
Treatment with dupilumab helps improve the signs and symptoms of erythrodermic atopic dermatitis, with the improvements occurring as early as the first week and being sustained over time, according to a study. The drug has an acceptable safety profile.
Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
04 Feb 2023Hormone therapies up ILD events in men with prostate cancer
Hormone therapy drugs, such as bicalutamide, flutamide, nilutamide, goserelin, degarelix, and apalutamide, appear to increase the likelihood of developing interstitial lung disease (ILD) events in patients with prostate cancer, reports a study.
Hormone therapies up ILD events in men with prostate cancer
04 Feb 2023Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
The addition of molnupiravir to usual care does not reduce hospitalization or death in vaccinated, community-dwelling individuals at high risk of serious outcomes of COVID-19, results of the UK-based PANORAMIC trial showed. However, it may provide other benefits such as reducing time to recovery.
Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
03 Feb 2023Prebiotic supplementation beneficial in mild to moderate ulcerative colitis
Oral supplementation with 1-kestose in patients with mild to moderate ulcerative colitis helps modulate the gut microbiome, which in turn contributes to clinical improvement, as reported in a study.